Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies

27 Aug 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Neurogenetic and Muscular Disorders Research
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36028610
DOI: 10.1007/s40272-022-00529-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental TherapiesPMID 36028610Read ↗

Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)Semantic proximity Read ↗

First drug to treat spinal muscular atrophy gets FDA approval: Costly injectable shown to stall debilitating muscle-wasting effects of rare genetic disorder.Semantic proximity Read ↗

Spinal muscular atrophy: from rags to riches.Semantic proximity Read ↗

Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)Semantic proximity Read ↗

Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent LandscapeSemantic proximity Read ↗

Perspectives on clinical trials in spinal muscular atrophy.Semantic proximity Read ↗

Therapy development in spinal muscular atrophySemantic proximity Read ↗

Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanismsSemantic proximity Read ↗

Rehabilitation management for patients with spinal muscular atrophy: a reviewSemantic proximity Read ↗

Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and NewSemantic proximity Read ↗

Nusinersen: A Review in 5q Spinal Muscular AtrophySemantic proximity Read ↗

Molecular therapies for the nervous system and muscle.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.